Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Zimmer Holdings, Inc. : Morning Research on Boston Scientific, Abbott Laboratories, Medtronic, Zimmer, and EnteroMedics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/02/2013 | 02:05pm CET

LONDON, April 2, 2013 /PRNewswire/ --

Medical appliances & equipment makers have been critical of President Obama's Affordable Care Act (ACA). Under the healthcare reform, medical appliances & equipment makers such as Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Medtronic Inc. (NYSE: MDT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM) are required to pay a 2.3% excise tax on U.S. sales. The industry has been lobbying to repeal the 2.3% tax on U.S. sales, saying that it would lead to higher costs and hamper research and development activities. Medical appliances & equipment makers ended mostly lower on Monday, tracking losses in the broad market. StockCall has posted free technical research reports on BSX, ABT, MDT, ZMH, and ETRM and these can be accessed by signing up at

http://www.stockcall.com/analysis

Shares of Boston Scientific Corporation touched a 52-week high of $7.86 yesterday, however, the stock failed to hold on to its gains. It closed 0.13% lower at $7.80 on above average volume of 29.66 million. Boston Scientific shares have gained more than 4.80% in the last three trading sessions. The stock has outperformed the broad market so far in 2013, gaining more than 36%. Its MACD has just crossed above the signal line, which is a strong bullish signal. Download the free report on BSX upon registration at

http://www.StockCall.com/BSX040213.pdf

Abbott Laboratories shares ended nearly flat in Monday's trading session. The stock fell to an intra-day low of $34.95 before paring most of its losses to finish the day 0.03% lower at $35.31 on volume of 6.03 million. The stock has gained nearly 2.80% in the last three sessions. Abbott's shares recently broke through $35 resistance level, which is a strong bullish signal. The positive trend is further confirmed by the stock's MACD chart. The company's shares are also trading above their 50-day and 200-day moving averages. ABT technical report can be accessed for free by signing up at

http://www.StockCall.com/ABT040213.pdf

Medtronic Inc.'s shares edged lower on Monday; however, the losses were limited. The stock closed 0.34% lower at $46.80 on volume of 2.81 million. The company's shares are currently trading close to their 52-week high of $47.40. The stock has outperformed the broad market in 2013, gaining more than 14%. Its shares are currently facing resistance at around $47. The stock's MACD is currently trading above the signal line and the zero-line, which is a bullish signal. The free report on MDT can be downloaded by signing up now at

http://www.StockCall.com/MDT040213.pdf

Zimmer Holdings Inc.'s shares ended marginally lower yesterday. The stock ended the day 0.12% lower at $75.13 on volume of 693,613. Its shares are currently hovering around their 52-week high of $76.75. The stock saw a series of highs last week, which is a bullish signal. The upbeat trend is further confirmed by recent volume activity and the stock's MACD chart. Free report on ZMH can be accessed by registering at

http://www.StockCall.com/ZMH040213.pdf

EnteroMedics Inc.'s shares rose sharply on Monday even as the broad market struggled. The stock closed 1% higher at $1.01 on volume of 776,418. EnteroMedics' shares touched an intra-day high of $1.04 yesterday. Despite the gains, the stock is down nearly 1% in the last three trading sessions. Shares of ETRM are currently trading well below their 50-day and 200-day moving averages. Register with StockCall and download the research on ETRM for free at

http://www.StockCall.com/ETRM040213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ZIMMER BIOMET HOLDINGS INC
01/21 ZIMMER BIOMET : Nominee-tied firm flagged in bribery
01/20 ZIMMER BIOMET HOLDINGS INC : ZBH SHAREHOLDER DEADLINE ALERT: Lundin Law PC Annou..
01/19 LIFSHITZ & MILLER LAW FIRM : Announces Investigation of Ally Financial Inc., Amp..
01/19 ZIMMER BIOMET : Company that HHS pick invested in faced criminal penalty
01/19 ZIMMER BIOMET : Company that Trump HHS pick invested in faced criminal fine
01/19 ZIMMER BIOMET HOLDINGS INC : Khang & Khang LLP Announces Securities Class Action..
01/19 ZBH The Law Offices of Vincent Wong Reminds Investors of a Class Action Invol..
01/18 ZIMMER BIOMET HOLDINGS INC : ZBH INVESTOR DEADLINE ALERT: Lundin Law PC Announce..
01/18 ZIMMER BIOMET : GPM Reminds Investors of the January 31 Deadline in the Class Ac..
01/18 ZIMMER BIOMET HOLDINGS, INC. : Change in Directors or Principal Officers, Financ..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
01/17DJLUXOTTICA FOUNDER : A Lifetime of Deals -- WSJ
01/17DJLUXOTTICA : Merger to Create Eyewear Giant -- WSJ
01/17DJWHAT'S NEWS : Business & Finance -- WSJ
01/16 ESSILOR INTL : Luxottica's merger helps Del Vecchio manage family risks
01/16DJLUXOTTICA : Another Big Splash by Italy's Eyewear King
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
01/21 D.R. Horton, Shell, FCX, senior loans among picks at Barron's Roundtable
01/20 DIVIDEND CHALLENGERS (AND NEAR-CHALL : 124 Increases Expected By March 31
01/18 Zimmer Biomet appoints new chief of Americas business
01/12 Zimmer Biomet resolves FCPA issues with DOJ and SEC, agrees to pay $30.5M
01/11 Medtech Mergers And Acquisitions Regresses To The Mean In 2016